BackInovio Pharmaceuticals Overview

Inovio Pharmaceuticals Current Cash

Inovio Pharmaceuticals's current cash is $26B.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$26.27B
↓ 34.18% YoYΔ $-13.64B vs prior year quarter

Peer average / median

Loading

Inovio Pharmaceuticals Current Cash History

Loading

Inovio Pharmaceuticals vs. peers: Current Cash Comparison

Loading

Inovio Pharmaceuticals Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Inovio Pharmaceuticals (INO) FAQ

As of the most recent data (March 2026), INO shows a current cash of $26B. That compares with $40B in the prior-year period — down 34.2% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, INO's current cash is now $26B (was $40B) — a 34.2% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Inovio Pharmaceuticals is outperforming or lagging.

Tracking INO's current cash over time shows whether Inovio Pharmaceuticals is scaling, shrinking, or reshaping that part of the business. The current reading is $26B That compares with $40B in the prior-year period — down 34.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has Inovio Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $26B) with ownership activity and broader fundamentals.

Inovio Pharmaceuticals's current cash is $26B; compare it with other Industrials names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.